Carboplatin Injection — FDA Drug Shortage

Current — Avyxa Pharma, LLC

The FDA lists a drug shortage record for Carboplatin Injection (injection) from Avyxa Pharma, LLC with status Current. The shortage was first posted on Apr 28, 2023.

Shortage details

Status
Current
Company
Avyxa Pharma, LLC
Package NDC
83831-142-50
Dosage Form
Injection
Presentation
Kyxata, Injection, 500 mg/50 mL (10 mg/mL) (NDC 83831-142-50)
Initial Posting
Apr 28, 2023

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.